Raffles Associates LINEAGE CELL THERAPEUTICS INC ownership

Watchlist

LINEAGE CELL THERAPEUTICS INC's ticker is LCTX and the CUSIP is 53566P109. A total of 126 filers reported holding LINEAGE CELL THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Raffles Associates ownership history of LINEAGE CELL THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$2,011
+51.0%
1,306,095
+140.3%
2.07%
+61.9%
Q4 2021$1,332
+464.4%
543,590
+480.8%
1.28%
+482.6%
Q3 2021$236
+90.3%
93,590
+114.7%
0.22%
+108.6%
Q2 2021$124
+21.6%
43,5900.0%0.10%
+1.0%
Q1 2021$102–43,590–0.10%–
 Download

External links